Genenta Science S.p.A. (NASDAQ:GNTA – Get Rating) – Equities research analysts at HC Wainwright issued their FY2027 earnings estimates for Genenta Science in a research note issued to investors on Wednesday, April 26th. HC Wainwright analyst J. Pantginis expects that the company will post earnings of $0.47 per share for the year. HC Wainwright currently […]
Genenta Science S.p.A. (NASDAQ:GNTA – Get Rating) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 500 shares, a drop of 66.7% from the February 28th total of 1,500 shares. Based on an average daily trading volume, of 4,700 shares, the short-interest ratio […]
Genenta Science (GNTA) Granted FDA Orphan Drug Designation for Temferon streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.